Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
46.00
Dollar change
-0.16
Percentage change
-0.35
%
IndexRUT P/E- EPS (ttm)-0.41 Insider Own14.80% Shs Outstand57.76M Perf Week0.22%
Market Cap2.67B Forward P/E235.85 EPS next Y0.20 Insider Trans-2.79% Shs Float49.54M Perf Month0.61%
Income-23.62M PEG- EPS next Q-0.20 Inst Own91.07% Short Float9.05% Perf Quarter1.72%
Sales520.66M P/S5.14 EPS this Y-1398.33% Inst Trans0.07% Short Ratio3.72 Perf Half Y-29.74%
Book/sh7.71 P/B5.97 EPS next Y143.39% ROA-4.04% Short Interest4.48M Perf Year-22.21%
Cash/sh1.75 P/C26.27 EPS next 5Y- ROE-5.41% 52W Range36.73 - 71.85 Perf YTD-29.14%
Dividend Est.- P/FCF129.45 EPS past 5Y32.83% ROI-4.95% 52W High-35.98% Beta1.00
Dividend TTM- Quick Ratio2.19 Sales past 5Y197.48% Gross Margin86.33% 52W Low25.24% ATR (14)1.97
Dividend Ex-Date- Current Ratio2.71 EPS Y/Y TTM23.19% Oper. Margin-1.75% RSI (14)48.38 Volatility4.98% 4.15%
Employees1300 Debt/Eq0.07 Sales Y/Y TTM26.10% Profit Margin-4.54% Recom1.45 Target Price65.82
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q-931.36% Payout- Rel Volume0.92 Prev Close46.16
Sales Surprise3.89% EPS Surprise-40.82% Sales Q/Q23.27% EarningsApr 30 AMC Avg Volume1.20M Price46.00
SMA20-4.25% SMA504.26% SMA200-14.95% Trades Volume1,109,032 Change-0.35%
Date Action Analyst Rating Change Price Target Change
Feb-29-24Downgrade Piper Sandler Overweight → Neutral $85 → $55
Jan-23-24Initiated Needham Buy $72
Jul-19-23Initiated Robert W. Baird Outperform $79
Oct-12-22Initiated Jefferies Buy $88
Sep-29-22Initiated Berenberg Buy $85
Sep-13-22Initiated Truist Hold $87
Jun-21-22Initiated Piper Sandler Overweight $100
Mar-23-22Resumed BofA Securities Buy $105
Dec-15-20Upgrade Wells Fargo Equal Weight → Overweight $79
Nov-18-20Initiated BTIG Research Buy $92
Jun-21-24 05:45AM
Jun-20-24 07:02PM
Jun-18-24 03:15PM
Jun-17-24 02:44PM
Jun-13-24 07:16PM
01:44PM Loading…
Jun-10-24 01:44PM
Jun-07-24 01:17PM
Jun-06-24 01:03PM
Jun-04-24 08:05AM
Jun-03-24 04:59PM
May-31-24 12:26PM
03:15AM
May-30-24 04:00AM
May-28-24 03:03PM
May-27-24 11:14AM
12:22PM Loading…
May-23-24 12:22PM
08:00AM
07:04AM
02:00AM
May-21-24 01:56PM
May-20-24 03:38PM
03:40AM
May-18-24 02:36AM
May-17-24 11:10AM
May-15-24 07:41AM
May-14-24 08:15PM
May-07-24 12:20PM
May-06-24 07:00AM
May-04-24 02:30AM
May-03-24 05:49PM
12:02PM Loading…
12:02PM
May-02-24 04:07PM
May-01-24 12:19PM
10:59AM
07:42AM
03:30AM
Apr-30-24 09:55PM
05:45PM
05:41PM
04:05PM
Apr-25-24 03:31PM
Apr-22-24 10:26AM
Apr-19-24 10:09AM
Apr-18-24 01:25PM
Apr-17-24 04:05PM
Apr-15-24 10:52AM
Apr-11-24 04:05PM
03:33PM
Apr-09-24 11:04AM
Apr-02-24 04:05PM
Mar-29-24 11:30AM
Mar-25-24 06:15PM
Mar-20-24 07:01PM
Mar-14-24 10:45AM
Mar-12-24 09:00PM
04:05PM
Mar-08-24 11:30PM
Mar-07-24 10:44AM
Feb-29-24 03:37PM
11:32AM
11:16AM
06:43AM
Feb-28-24 04:37PM
04:05PM
Feb-14-24 04:05PM
Jan-23-24 07:16AM
Jan-15-24 03:13AM
Jan-12-24 12:16PM
Jan-09-24 06:30AM
Jan-08-24 09:00AM
Dec-20-23 04:01PM
Dec-15-23 07:24AM
Dec-01-23 11:31AM
Nov-30-23 11:19AM
Nov-27-23 04:20PM
Nov-18-23 07:03AM
Nov-15-23 04:05PM
07:59AM
Nov-06-23 09:35AM
Nov-03-23 12:27PM
10:59AM
10:31AM
08:59AM
07:01AM
Nov-02-23 07:16PM
04:01PM
11:03AM
11:02AM
10:24AM
Nov-01-23 06:54PM
05:01PM
04:02PM
04:01PM
11:07AM
09:53AM
Oct-31-23 07:37AM
07:33AM
Oct-30-23 09:48AM
Oct-27-23 10:12AM
08:08AM
Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hoffman WilliamDirectorJun 17 '24Sale43.5440,0001,741,579825,359Jun 20 04:39 PM
Hill, Mitch C.Chief Financial OfficerJun 12 '24Option Exercise0.465,0002,285186,294Jun 14 04:52 PM
Hill, Mitch C.Chief Financial OfficerJun 12 '24Sale47.605,000237,977181,294Jun 14 04:52 PM
Hoffman WilliamDirectorMay 28 '24Sale50.1360,0003,007,800865,359May 30 07:10 PM
Hykes AndrewPresident and CEOMay 28 '24Sale50.003,000150,000465,474May 30 07:14 PM
Chambers RebeccaDirectorMay 20 '24Sale45.3996443,7569,944May 21 06:57 PM
Hoffman WilliamDirectorMay 16 '24Sale46.6040,0001,863,977925,359May 17 06:07 PM
Hill, Mitch C.Chief Financial OfficerMay 13 '24Option Exercise0.466,0002,742187,294May 15 04:39 PM
Hill, Mitch C.Chief Financial OfficerMay 13 '24Sale45.976,000275,812181,294May 15 04:39 PM
Hoffman WilliamDirectorMay 01 '24Sale42.0038,5491,619,047965,359May 03 05:40 PM
Hoffman WilliamDirectorApr 16 '24Sale40.001,45158,040999,782Apr 18 06:38 PM
Hill, Mitch C.Chief Financial OfficerApr 12 '24Option Exercise0.466,0002,742187,294Apr 16 04:32 PM
Hill, Mitch C.Chief Financial OfficerApr 12 '24Sale40.966,000245,760181,294Apr 16 04:32 PM
Hoffman WilliamDirectorMar 18 '24Sale41.1340,0001,645,0791,003,296Mar 20 04:34 PM
Hill, Mitch C.Chief Financial OfficerMar 12 '24Option Exercise0.466,0002,742189,361Mar 14 04:31 PM
Hill, Mitch C.Chief Financial OfficerMar 12 '24Sale41.916,000251,461183,361Mar 14 04:31 PM
Hoffman WilliamDirectorDec 15 '23Sale65.0825,0001,627,0731,045,493Dec 19 05:18 PM
Hill, Mitch C.Chief Financial OfficerDec 12 '23Option Exercise0.466,5002,970176,730Dec 14 04:35 PM
Hill, Mitch C.Chief Financial OfficerDec 12 '23Sale62.756,500407,855170,230Dec 14 04:35 PM
Hoffman WilliamDirectorDec 04 '23Option Exercise0.43103,49244,3361,070,493Dec 06 05:07 PM
Hykes AndrewPresident and CEONov 16 '23Sale59.8237,4482,240,277434,817Nov 17 07:17 PM
Tu ThomasChief Medical OfficerNov 16 '23Sale59.8225,4511,522,573320,932Nov 17 07:19 PM
Hoffman WilliamDirectorNov 15 '23Sale61.2425,0001,531,124967,001Nov 17 06:27 PM
Hill, Mitch C.Chief Financial OfficerNov 13 '23Option Exercise0.466,5002,970176,730Nov 15 04:32 PM
Hill, Mitch C.Chief Financial OfficerNov 13 '23Sale56.066,500364,366170,230Nov 15 04:32 PM
MILDER DONALD BDirectorNov 08 '23Buy53.482,100112,3033,031,714Nov 08 05:48 PM
MILDER DONALD BDirectorNov 07 '23Buy53.4454,0002,885,7603,029,614Nov 08 05:48 PM
Hoffman WilliamDirectorOct 16 '23Sale57.2825,0001,432,098992,001Oct 18 05:39 PM
Hill, Mitch C.Chief Financial OfficerOct 12 '23Option Exercise0.466,5002,970176,730Oct 16 04:32 PM
Hill, Mitch C.Chief Financial OfficerOct 12 '23Sale55.746,500362,340170,230Oct 16 04:32 PM
Hoffman WilliamDirectorSep 15 '23Sale66.7425,0001,668,5031,023,055Sep 19 04:38 PM
Hill, Mitch C.Chief Financial OfficerSep 12 '23Option Exercise0.466,5002,970178,302Sep 14 04:41 PM
Hill, Mitch C.Chief Financial OfficerSep 12 '23Sale67.856,500441,040171,802Sep 14 04:41 PM
Hykes AndrewPresident and CEOAug 16 '23Sale66.1136,6762,424,829475,132Aug 18 05:05 PM
Tu ThomasChief Medical OfficerAug 16 '23Sale66.1124,9261,647,980347,997Aug 18 05:01 PM
Hoffman WilliamDirectorAug 15 '23Sale69.0225,0001,725,5371,048,055Aug 17 04:46 PM
Hill, Mitch C.Chief Financial OfficerAug 14 '23Option Exercise0.466,5002,970178,302Aug 16 04:46 PM
Hill, Mitch C.Chief Financial OfficerAug 14 '23Sale70.476,500458,053171,802Aug 16 04:46 PM
Hoffman WilliamDirectorJul 17 '23Sale57.0825,0001,426,9141,073,055Jul 19 04:32 PM
Hill, Mitch C.Chief Financial OfficerJul 12 '23Option Exercise0.466,5002,970177,982Jul 14 04:35 PM
Hill, Mitch C.Chief Financial OfficerJul 12 '23Sale56.246,500365,540171,482Jul 14 04:35 PM